IBANDRONATE Side Effects

5963816-6 | Exostosis, Jaw Disorder
on Nov 21, 2008 Female patient from UNITED STATES , 50 years of age, weighting 187.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Ibandronate (View Usage). Patient experienced the following unwanted or unexpected effects: exostosis, jaw disorder. Ibandronate dosage: 150 Q Month Po. During the same period patient was treated with ALENDRONATE SODIUM (70 Mg Q Week Po) (View Alendronate Sodium Review and Alendronate Sodium Label ).

5027881-5 | Osteonecrosis
Patient was taking Ibandronate (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Jun 07, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, weighting 154.8 lb, . Ibandronate dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ANASTROZOL (View Anastrozol Review and Anastrozol Label ), ZOMETA (View Zometa Review and Zometa Label ).

4890005-9 | Spinal Column Stenosis
Adverse event was reported on Jan 11, 2006 by a Female patient taking Ibandronate (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: GERMANY , 81 years of age, weighting 165.3 lb, After Ibandronate was administered, patient had the following side effects: spinal column stenosis. During the same period patient was treated with CAPECITABINE (As Per Protocol Dose Given On Days 1 To 14 Every Three Weeks Dose Reported As ^6 Up^) (View Capecitabine Review and Capecitabine Label ), ANASTROZOL (View Anastrozol Review and Anastrozol Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), DELIX 5 PLUS (View Delix 5 Plus Review and Delix 5 Plus Label ), VITAMIN B COMPLEX CAP (Reported As Daily.) (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), PALLADON (View Palladon Review and Palladon Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), MOVICOL (View Movicol Review and Movicol Label ).

4883767-8 | Cardiac Pacemaker Insertion, Dyspnoea, Electrocardiogram Abnormal, Syncope
on Dec 22, 2005 Female patient from UNITED STATES , 75 years of age, weighting 188.9 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Ibandronate (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac pacemaker insertion, dyspnoea, electrocardiogram abnormal, syncope. Ibandronate dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.


4780248-7 | Thrombosis
on Sep 15, 2005 Female patient from GERMANY , 66 years of age, weighting 114.6 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ibandronate (View Usage). Patient had the following side effects: thrombosis. Ibandronate dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ).